Sequential therapy with fludarabine, high dose cyclophosphamide, and rituximab improves the quality of response in patients with previously untreated chronic lymphocytic leukemia.

被引：0
|
作者：
Weiss, MA [1 ]
Lamanna, N [1 ]
Gencarelli, A [1 ]
Scheinberg, DA [1 ]
Maslak, PG [1 ]
Horgan, D [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY 10021 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5019
引用
收藏
页码：365B / 365B
页数：1
相关论文
共 50 条
  • [11] Combination fludarabine, cyclophosphamide and rituximab for previously treated patients with chronic lymphocytic leukemia (CLL).
    Garcia-Manero, G
    O'Brien, S
    Cortes, J
    Giles, F
    Faderl, S
    Lerner, S
    Albitar, M
    Kantarjian, HM
    Keating, MJ
    BLOOD, 2000, 96 (11) : 757A - 757A
  • [12] Early results of modified fludarabine, cyclophosphamide, and rituximab (mFCR) for patients with previously untreated advanced chronic lymphocytic leukemia (CLL).
    Tarhini, A. A.
    Land, S.
    Lim, F.
    Kiefer, G. J.
    Pietragallo, L.
    Pinkerton, R. A.
    Sulecki, M.
    Meisner, D.
    Schaefer, P. M.
    Foon, K. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 360S - 360S
  • [13] Long-Term Survival After Fludarabine, Cyclophosphamide, and Rituximab Treatment in Previously Untreated Chronic Lymphocytic Leukemia Patients
    Mustafa, Shokhan Mohammad
    Yassin, Ahmed Khudair
    Hassan, Kawa M.
    Sadiq, Nawsherwan
    Nadihm, Marwa N.
    Abdulrahman, Lara Lateef
    Salahaden, Shlan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S263 - S264
  • [14] Long-term survival after fludarabine, cyclophosphamide, and rituximab treatment in previously untreated chronic lymphocytic leukemia patients
    Mustafa, Shokhan Mohammad
    Yassin, Ahmed Khudair
    Mohammed, Nawsherwan S.
    Shamoon, Rawand P.
    Karam, Marwa N.
    Mohammad, Shlan S.
    Abdulrahman, Lara Lateef
    Ahmed, Zhalla O.
    Rashid, Bryar Sabah
    Mahmood, Tavan, I
    Yousif, Rozhhat A.
    Hasan, Kawa M.
    Mohamed, Zeki A.
    Getta, Hisham A.
    Jalal, Sana D.
    Abdullah, Dana A.
    Abdulla, Basil K.
    Numan, Ghanim S.
    Karadagh, Ranan
    IRAQI JOURNAL OF HEMATOLOGY, 2021, 10 (02) : 139 - 145
  • [15] Long-Term Survival After Fludarabine, Cyclophosphamide, and Rituximab Treatment in Previously Untreated Chronic Lymphocytic Leukemia Patients
    Mustafa, Shokhan Mohammad
    Yassin, Ahmed Khudair
    Mohammed, Nawsherwan S.
    Shamoon, Rawand P.
    Karma, Marwa N.
    Mohammad, Shlan S.
    Abdulrahman, Lara Lateef
    Ahmed, Zhalla O.
    Rashid, Bryar Sabah
    Mahmood, Tavan I.
    Yousif, Rozhhat A.
    Hasan, Kawa M.
    Mohamed, Zaki A.
    Getta, Hisham A.
    Jalal, Sana D.
    Abdullah, Dana A.
    Abdulla, Basil K.
    Numan, Ghanim S.
    Karadagh, Ranan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S260 - S261
  • [16] Fludarabine, cyclophosphamide, and multiple-dose rituximab as frontline therapy for chronic lymphocytic leukemia
    Short, Nicholas J.
    Keating, Michael J.
    Wierda, William G.
    Faderl, Stefan
    Ferrajoli, Alessandra
    Estrov, Zeev
    Smith, Susan C.
    O'Brien, Susan M.
    CANCER, 2015, 121 (21) : 3869 - 3876
  • [17] High dose Rituximab in chronic lymphocytic leukemia.
    Jain, D
    Dutcher, JP
    Wiernik, PH
    BLOOD, 2003, 102 (11) : 359B - 360B
  • [18] Fludarabine and cyclophosphamide achieves high complete response rate in patients with previously untreated chronic lymphocytic leukemia: ECOG 1997.
    Flinn, IW
    Jemiai, Y
    Bennett, JM
    Falkson, CI
    Flynn, P
    Pundaleeka, S
    Stadtmauer, E
    Schnell, F
    Grever, M
    Tallman, MS
    Rowe, JM
    BLOOD, 2001, 98 (11) : 633A - 633A
  • [19] The Addition of Rituximab to Fludarabine and Cyclophosphamide Improves Progression-free Survival in Patients with Previously Treated Chronic Lymphocytic Leukemia
    Mahipal, Amit
    Weiss, Mark
    CURRENT ONCOLOGY REPORTS, 2010, 12 (06) : 352 - 354
  • [20] The Addition of Rituximab to Fludarabine and Cyclophosphamide Improves Progression-free Survival in Patients with Previously Treated Chronic Lymphocytic Leukemia
    Amit Mahipal
    Mark Weiss
    Current Oncology Reports, 2010, 12 : 352 - 354
12345